Irwin Ho

595 total citations
18 papers, 504 citations indexed

About

Irwin Ho is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Molecular Medicine. According to data from OpenAlex, Irwin Ho has authored 18 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 5 papers in Pediatrics, Perinatology and Child Health and 5 papers in Molecular Medicine. Recurrent topics in Irwin Ho's work include Antibiotics Pharmacokinetics and Efficacy (7 papers), Antibiotic Resistance in Bacteria (5 papers) and Pharmaceutical studies and practices (4 papers). Irwin Ho is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (7 papers), Antibiotic Resistance in Bacteria (5 papers) and Pharmaceutical studies and practices (4 papers). Irwin Ho collaborates with scholars based in United States, France and Canada. Irwin Ho's co-authors include Surendra K. Puri, Howard B. Lassman, Marcia Divoll, Richard I. Shader, Harold C. Neu, P Aswapokee, Kwung P. Fu, Charles Matthijssen, James T. Doluisio and Robert V. Smith and has published in prestigious journals such as Journal of the American Statistical Association, Antimicrobial Agents and Chemotherapy and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Irwin Ho

18 papers receiving 453 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Irwin Ho United States	12	226	91	90	89	86	18	504
J. Gaillot France	12	162 0.7×	73 0.8×	66 0.7×	45 0.5×	45 0.5×	31	509
W. D. Paar Germany	8	178 0.8×	59 0.6×	82 0.9×	119 1.3×	42 0.5×	14	537
B. Holmes United States	12	187 0.8×	110 1.2×	64 0.7×	50 0.6×	58 0.7×	21	747
L. G. Gisclon United States	10	228 1.0×	131 1.4×	158 1.8×	218 2.4×	93 1.1×	16	579
A. Van Hecken Belgium	11	174 0.8×	60 0.7×	46 0.5×	44 0.5×	36 0.4×	14	487
EJ Begg New Zealand	13	283 1.3×	178 2.0×	76 0.8×	214 2.4×	64 0.7×	19	851
J. Rieder Austria	19	179 0.8×	155 1.7×	41 0.5×	94 1.1×	40 0.5×	43	856
E. F. S. Termond Netherlands	12	124 0.5×	34 0.4×	86 1.0×	88 1.0×	20 0.2×	25	541
Edward J. Mroszczak United States	13	360 1.6×	54 0.6×	28 0.3×	59 0.7×	41 0.5×	26	794
Heather A. Friedel	10	149 0.7×	145 1.6×	32 0.4×	50 0.6×	35 0.4×	11	797

Countries citing papers authored by Irwin Ho

Since Specialization

Citations

This map shows the geographic impact of Irwin Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irwin Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irwin Ho more than expected).

Fields of papers citing papers by Irwin Ho

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irwin Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irwin Ho. The network helps show where Irwin Ho may publish in the future.

Co-authorship network of co-authors of Irwin Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Irwin Ho. A scholar is included among the top collaborators of Irwin Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irwin Ho. Irwin Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Aly, Raza, Howard I. Maïbach, Irwin Ho, & Beatrice Abrams. (1992). SIMPLIFIED EXPERIMENTAL HUMAN DERMATOPHYTOSIS MODEL. International Journal of Dermatology. 31(2). 122–125. 2 indexed citations

Puri, Surendra K., et al.. (1990). Multiple Dose Pharmacokinetics, Safety, and Tolerance of Velnacrine (HP 029) in Healthy Elderly Subjects: A Potential Therapeutic Agent for Alzheimer's Disease. The Journal of Clinical Pharmacology. 30(10). 948–955. 23 indexed citations

Halstenson, C E, John A. Opsahl, Michael H. Schwenk, et al.. (1990). Disposition of roxithromycin in patients with normal and severely impaired renal function. Antimicrobial Agents and Chemotherapy. 34(3). 385–389. 14 indexed citations

Rockhold, Robin W., et al.. (1989). Changes in drinking activity, urine volume and urinary electrolyte excretion after intracerebroventricular administration of diisopropylfluorophosphate.. Journal of Pharmacology and Experimental Therapeutics. 250(1). 202–209. 5 indexed citations

Puri, Surendra K., et al.. (1989). Single Dose Safety, Tolerance, and Pharmacokinetics of HP 029 in Healthy Young Men: A Potential Alzheimer Agent. The Journal of Clinical Pharmacology. 29(3). 278–284. 23 indexed citations

Puri, Surendra K., et al.. (1989). The Effect of Food on the Bioavailability of Velnacrine (HP 029) in Healthy Elderly Men: A Potential Alzheimer Agent. The Journal of Clinical Pharmacology. 29(10). 956–960. 9 indexed citations

Lassman, Howard B., et al.. (1988). Pharmacokinetics of Roxithromycin (RU 965). The Journal of Clinical Pharmacology. 28(2). 141–152. 26 indexed citations

Lassman, Howard B., et al.. (1988). Pharmakodynamik und Pharmakokinetik des neuen H2-Rezeptorantagonisten Roxatidinacetat nach multiplen Dosen bei gesunden Männern. Drugs. 35(Supplement 3). 53–64. 9 indexed citations

Smith, Robert V., et al.. (1986). Pharmacokinetics of Orally Administered Pentoxifylline in Humans. Journal of Pharmaceutical Sciences. 75(1). 47–52. 86 indexed citations

10.

Plouffe, Joseph F., Robert L. Perkins, Robert J. Fass, et al.. (1983). Cefotaxime: Pharmacokinetics and in vitro Antibacterial Activity of Serum and Urine in Normal Human Volunteers. Chemotherapy. 29(2). 73–79. 4 indexed citations

11.

Greenblatt, David J., Marcia Divoll, Surendra K. Puri, et al.. (1983). Reduced Single-dose Clearance of Clobazam in Elderly Men Predicts Increased Multiple-dose Accumulation1. Clinical Pharmacokinetics. 8(1). 83–94. 27 indexed citations

12.

Divoll, Marcia, David J. Greenblatt, Domenic A. Ciraulo, et al.. (1982). Clobazam Kinetics: Intrasubject Variability and Effect of Food on Absorption. The Journal of Clinical Pharmacology. 22(1). 69–73. 39 indexed citations

13.

Wills, Robert J., et al.. (1981). Influence of Food on the Bioavailability of Trental® (Pentoxifylline) in Man. Drug Development and Industrial Pharmacy. 7(4). 385–396. 11 indexed citations

14.

Greenblatt, D J, et al.. (1981). Clobazam kinetics in the elderly.. British Journal of Clinical Pharmacology. 12(5). 631–636. 66 indexed citations

15.

Neu, Harold C., P Aswapokee, Kwung P. Fu, Irwin Ho, & Charles Matthijssen. (1980). Cefotaxime kinetics after intravenous and intramuscular injection of single and multiple doses. Clinical Pharmacology & Therapeutics. 27(5). 677–685. 32 indexed citations

16.

Guibert, J, et al.. (1980). Pharmacokinetics of cefotaxime in normal human volunteers. Journal of Antimicrobial Chemotherapy. 6(suppl A). 83–92. 50 indexed citations

17.

Fu, Kwung P., P Aswapokee, Irwin Ho, Charles Matthijssen, & Harold C. Neu. (1979). Pharmacokinetics of cefotaxime. Antimicrobial Agents and Chemotherapy. 16(5). 592–597. 64 indexed citations

18.

Halperin, Max, et al.. (1967). Shorter Confidence Bands in Linear Regression. Journal of the American Statistical Association. 62(319). 1050–1067. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact